Autologous Nucleus Pulposus Cells (aNPC) Therapy

autologous nucleus pulposus cell therapy · ASTEROGENE Biomedical Co. Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Autologous Nucleus Pulposus Cells (aNPC) Therapy, covering 2026-04-03 to 2026-04-03. Get the full timeline:

Most recent: Clinical Trial Update: EvaluatIon of Autologous Nucleus Pulposus Cells (aNPC) in Degenerative Disc Disease [Phase 1, Phase 2]